Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
NCT ID: NCT03502616
Last Updated: 2021-09-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
270 participants
INTERVENTIONAL
2018-06-07
2020-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
NCT01786668
ToFAcitinib in Early Active Axial SpondyloarThritis:
NCT06112665
A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis
NCT03178487
Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
NCT03738956
Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis
NCT00809159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tofacitinib
Tofacitinib
Oral administration twice per day
Placebo
Tofacitinib
Oral administration twice per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tofacitinib
Oral administration twice per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have a radiograph of SI joints (AP Pelvis) documenting diagnosis of AS.
* Has active disease despite nonsteroidal anti-inflammatory drug (NSAID) therapy or intolerant to NSAIDs.
Exclusion Criteria
* History of allergies, intolerance or hypersensitivity to lactose or tofacitinib.
* History of any other rheumatic disease.
* Any subject with condition affecting oral drug absorption.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rheumatology Associates of North Alabama, PC
Huntsville, Alabama, United States
Arizona Arthritis & Rheumatology Associates, P.C.
Gilbert, Arizona, United States
Medvin Clinical Research
Covina, California, United States
Rheumatology Center of San Diego PC
San Diego, California, United States
University of California, San Francisco Medical Center
San Francisco, California, United States
Robin K. Dore, MD, Inc.
Tustin, California, United States
New England Research Associates, LLC
Bridgeport, Connecticut, United States
Advanced Radiology
Stamford, Connecticut, United States
Stamford Therapeutics Consortium
Stamford, Connecticut, United States
Southcoast Research Center, Inc.
Miami, Florida, United States
Millennium Research
Ormond Beach, Florida, United States
Bluegrass Community Research, Inc
Lexington, Kentucky, United States
Center for Rheumatology and Bone Research
Wheaton, Maryland, United States
M3-Emerging Medical Research, LLC
Durham, North Carolina, United States
Paramount Medical Research and Consulting, LLC
Middleburg Heights, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
Altoona Center For Clinical Research
Duncansville, Pennsylvania, United States
Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology
Summerville, South Carolina, United States
Precision Comprehensive Clinical Research Solutions
Colleyville, Texas, United States
Adriana Pop-Moody MD - Clinic PA
Corpus Christi, Texas, United States
Metroplex Clinical Research Center
Dallas, Texas, United States
Clinical Research Unit
Houston, Texas, United States
Investigational Drug Services
Houston, Texas, United States
Memorial Hermann Hospital Imaging
Houston, Texas, United States
Southwest Rheumatology Research LLC
Mesquite, Texas, United States
Trinity Universal Research Associates, Inc.
Plano, Texas, United States
Advanced Rheumatology of Houston
The Woodlands, Texas, United States
Arthritis Northwest, PLLC
Spokane, Washington, United States
Pacific Radiology,
Maroochydore, Queensland, Australia
Rheumatology Research Unit Sunshine Coast
Maroochydore, Queensland, Australia
Emeritus Research Pty. Ltd.
Camberwell, Victoria, Australia
Melbourne Radiology Clinic
East Melbourne, Victoria, Australia
SKG Radiology
Subiaco, Western Australia, Australia
Western Cardiology
Subiaco, Western Australia, Australia
RK Will Pty Ltd
Victoria Park, Western Australia, Australia
Multiprofile Hospital for active treatment "Kaspela" EOOD
Plovdiv, , Bulgaria
Diagnostic-Consulting Center XVII - Sofia
Sofia, , Bulgaria
Medical Centre Synexus Sofia EOOD
Sofia, , Bulgaria
G.R.M.O. (Groupe de recherche en maladies osseuses) Inc.
Québec, Quebec, Canada
Centre de Recherche Musculo-Squelettique
Trois-Rivières, Quebec, Canada
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
The Third Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
The First Affiliated Hosptial of Wenzhou Medical University
Wenzhou, Zhejiang, China
Rheumatology and Immunology Department, Shanghai Changzheng Hospital
Shanghai, , China
Lekarna Rezidence Nova Karolina
Ostrava, , Czechia
CCBR Ostrava s.r.o.
Ostrava, , Czechia
BENU Lekarna
Pardubice, , Czechia
CCR, Czech a.s.
Pardubice, , Czechia
Lekarna Hradebni, s.r.o.
Uherské Hradiště, , Czechia
Uherskohradistska nemocnice, a.s.
Uherské Hradiště, , Czechia
Medical Plus s.r.o.
Uherské Hradiště, , Czechia
CHRU de Tours, Hopital Trousseau
Tours, , France
Qualiclinic K ft
Budapest, , Hungary
Pest megyei Flór Ferenc Kórház, Reumatológia-és Fizioterápiás Osztály
Kistarcsa, , Hungary
VITAL MEDICAL CENTER (VITÁL-MEDICINA Kft.)
Veszprém, , Hungary
Barzilai Medical Center
Ashkelon, , Israel
Geo Medical Sp. z.o.o Szpital Geo Medical
Katowice, , Poland
Moja Przychodnia
Katowice, , Poland
C.M. Silmedic Sp. z o.o.
Katowice, , Poland
Malopolskie Badania Kliniczne Sp. z o.o. s.k.
Krakow, , Poland
Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA
Krakow, , Poland
Centrum Medyczne Plejady
Krakow, , Poland
Centrum Medyczne LUX MED
Krakow, , Poland
Malopolskie Centrum Medyczne S.C.
Krakow, , Poland
Szpital Uniwersytecki w Krakowie, Zaklad Radiologii
Krakow, , Poland
Top Medical
Lublin, , Poland
Zespol Poradni Specjalistycznych REUMED, Wallenroda Filia nr 1
Lublin, , Poland
NZOZ JAMED Pracownia Rentgenowska Jerema Antoszewski
Poznan, , Poland
Prywatna Praktyka Lekarska Prof. UM dr hab. med. Pawel Hrycaj
Poznan, , Poland
Klinika Alfa
Sochaczew, , Poland
RCMed Oddzial Sochaczew
Sochaczew, , Poland
Szpital Powiatowy w Sochaczewie
Sochaczew, , Poland
Szpital Sw. Elzbiety, Mokotowskie Centrum Medyczne, Zaklad Diagnostyki
Warsaw, , Poland
"Reumatika - Centrum Reumatologii" NZOZ
Warsaw, , Poland
Centrum Medyczne Oporow
Wroclaw, , Poland
Centrum Medyczne Medix
Wroclaw, , Poland
Limited Liability Company Medical Center "Rheuma-Med"
Kemerovo, , Russia
State Budgetary Healthcare Institution "Orenburg Regional Clinical Hospital"
Orenburg, , Russia
Limited Liability Company "Sanavita"
Saint Petersburg, , Russia
State Healthcare Institution "Regional Clinical Hospital"
Saratov, , Russia
RSBHI "Smolensk Regional Clinical Hospital"
Smolensk, , Russia
Limited Liability Company "BioMed"
Vladimir, , Russia
Chonnam National University Hospital
Gwangju, , South Korea
Inha University Hospital
Incheon, , South Korea
Hanyang University Seoul Hospital
Seoul, , South Korea
Ankara Universitesi Tip Fakultesi Ibn-i Sina Hastanesi
Ankara, , Turkey (Türkiye)
Ankara Universitesi Tip Fakultesi, Ibn-i Sina Hastanesi
Ankara, , Turkey (Türkiye)
Hacettepe Universitesi Tip Fakultesi, Ic Hastaliklari Anabilim
Ankara, , Turkey (Türkiye)
Istanbul Universitesi Istanbul Tip Fakultesi, Ic Hastaliklari
Istanbul, , Turkey (Türkiye)
Istanbul Universitesi Istanbul Tip Fakultesi
Istanbul, , Turkey (Türkiye)
Marmara Univ. Istanbul Pendik Egitim ve Arastirma Hastanesi
Istanbul, , Turkey (Türkiye)
Izmir Katip Celebi Univ Ataturk Egitim ve Arastirma Hastanesi
Izmir, , Turkey (Türkiye)
Izmir Katip Celebi Univ. Ataturk Egitim ve Arastirma Hastanesi
Izmir, , Turkey (Türkiye)
Kyiv City Clinical Hospital # 3, Rheumatology Department
Kyiv, , Ukraine
Lviv Communal Clinical Hospital #4, Rheumatology department
Lviv, , Ukraine
Military-Medical Clinical Center (Clinical Hospital with 200 beds) of State Border Guard Service of
Lviv, , Ukraine
Ternopil University Hospital, Department of Rheumatology,
Ternopil, , Ukraine
Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrohov, rheumatology department,
Vinnytsia, , Ukraine
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Deodhar A, Akar S, Curtis JR, El-Zorkany B, Magrey M, Wang C, Wu J, Makgoeng SB, Vranic I, Menon S, Fleishaker DL, Diehl AM, Fallon L, Yndestad A, Landewe RBM. Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis. Adv Rheumatol. 2024 Dec 18;64(1):87. doi: 10.1186/s42358-024-00402-x.
Gossec L, Walsh JA, Sengupta R, Bushmakin AG, Cappelleri JC, Yndestad A, Dina O, Cella D. Improvement of Fatigue in Patients with Ankylosing Spondylitis Receiving Tofacitinib: Analyses of a Phase 3 Randomized Controlled Trial. Rheumatol Ther. 2025 Feb;12(1):85-98. doi: 10.1007/s40744-024-00727-5. Epub 2024 Dec 13.
Norton H, Sliwinska-Stanczyk P, Hala T, El-Zorkany B, Stockert L, Mundayat R, Wang L, Ritchlin CT. Tofacitinib Efficacy/Safety in Patients with Ankylosing Spondylitis by Baseline Body Mass Index: A Post Hoc Analysis of Phase 2/3 Trials. Rheumatol Ther. 2025 Feb;12(1):67-84. doi: 10.1007/s40744-024-00726-6. Epub 2024 Dec 5.
Ogdie A, Kristensen LE, Soriano ER, Akar S, Sun Y, Gruben D, Fallon L, Kinch CD, Gladman DD. Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status. Rheumatol Ther. 2024 Dec;11(6):1649-1664. doi: 10.1007/s40744-024-00711-z. Epub 2024 Sep 25.
Deodhar A, Baraliakos X, Magrey M, Gensler LS, Thorat AV, Pemmaraju SK, Cadatal MJ, Nash P. Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials. J Rheumatol. 2024 Aug 1;51(8):772-780. doi: 10.3899/jrheum.2023-1198.
Navarro-Compan V, Deodhar A, Bahiri R, Bushmakin AG, Cappelleri JC, Rammaoui J. Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis. Arthritis Res Ther. 2024 May 24;26(1):105. doi: 10.1186/s13075-024-03313-w.
Kristensen LE, Deodhar A, Leung YY, Vranic I, Mortezavi M, Fallon L, Yndestad A, Kinch CD, Gladman DD. Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatol Ther. 2024 Jun;11(3):487-499. doi: 10.1007/s40744-024-00662-5. Epub 2024 May 2.
Magrey M, Wei JC, Yndestad A, Bushmakin AG, Cappelleri JC, Dina O, Deodhar A. Relationships of Work Productivity and Activity Impairment With Patient-Reported Outcomes in Ankylosing Spondylitis: Results From Two Trials. Arthritis Care Res (Hoboken). 2024 Mar;76(3):359-365. doi: 10.1002/acr.25267. Epub 2024 Jan 5.
Cella D, Lenderking WR, Chongpinitchai P, Bushmakin AG, Dina O, Wang L, Cappelleri JC, Navarro-Compan V. Functional Assessment of Chronic Illness Therapy-Fatigue is a reliable and valid measure in patients with active ankylosing spondylitis. J Patient Rep Outcomes. 2022 Sep 23;6(1):100. doi: 10.1186/s41687-022-00508-0.
Navarro-Compan V, Wei JC, Van den Bosch F, Magrey M, Wang L, Fleishaker D, Cappelleri JC, Wang C, Wu J, Dina O, Fallon L, Strand V. Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial. RMD Open. 2022 Jun;8(2):e002253. doi: 10.1136/rmdopen-2022-002253.
Deodhar A, Sliwinska-Stanczyk P, Xu H, Baraliakos X, Gensler LS, Fleishaker D, Wang L, Wu J, Menon S, Wang C, Dina O, Fallon L, Kanik KS, van der Heijde D. Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2021 Aug;80(8):1004-1013. doi: 10.1136/annrheumdis-2020-219601. Epub 2021 Apr 27.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AS
Identifier Type: OTHER
Identifier Source: secondary_id
2018-000226-58
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
A3921120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.